Aguiar C, Therrien J, Lemire P, Segura M, Smith L C, Theoret C L
Département de Biomédecine Vétérinaire, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada.
Département de Pathologie et Microbiologie, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada.
Equine Vet J. 2016 May;48(3):338-45. doi: 10.1111/evj.12438. Epub 2015 May 29.
Skin trauma in horses often leads to the development of chronic nonhealing wounds that lack a keratinocyte cover, vital for healing. Reports in mouse and man confirm the possibility of generating functional keratinocytes from induced pluripotent stem cells (iPSC), thus presenting myriad potential applications for wound management or treatment of skin disease. Similarly, differentiation of equine iPSC (eiPSC) into a keratinocyte lineage should provide opportunities for the advancement of veterinary regenerative medicine.
The purpose of this study was to develop an efficient method for the differentiation of eiPSC into a keratinocyte lineage. It was hypothesised that eiPSC can form differentiated keratinocytes (eiPSC-KC) comparable with primary equine keratinocytes (PEK) in their morphological and functional characteristics.
Experimental in vitro study.
Equine iPSC established using a nonviral system were treated for 30 days with retinoic acid and bone morphogenetic protein-4 to induce directed differentiation into iPSC-KC. Temporospatial gene and protein expression by eiPSC-KC was measured at weekly intervals of differentiation and in response to calcium switch. Proliferative and migratory capacities of eiPSC-KC were compared with those of PEK.
Equine iPSC, upon directed differentiation, showed loss of pluripotency genes and progressive increase in pancytokeratin expression indicating ectodermal specification into keratinocytes. High differentiation efficiency was achieved, with 82.5% of eiPSC expressing keratin 14, a marker of epidermal-specific basal stem cells, after 30 days of directed differentiation. Moreover, the proliferative capacity of eiPSC-KC was superior, while the migratory capacity (measured as the ability to epithelise in vitro wounds) was comparable with that of PEK.
This proof of concept study suggests that eiPSC can successfully be differentiated into equine keratinocytes (eiPSC-KC) with features that are promising to the development of a stem cell-based skin construct, with the potential to regenerate lost or damaged skin.
马的皮肤创伤常导致慢性不愈合伤口的形成,这些伤口缺乏对愈合至关重要的角质形成细胞覆盖。小鼠和人类的报告证实了从诱导多能干细胞(iPSC)产生功能性角质形成细胞的可能性,从而为伤口管理或皮肤病治疗提供了无数潜在应用。同样,马iPSC(eiPSC)向角质形成细胞谱系的分化应为兽医再生医学的发展提供机会。
本研究的目的是开发一种将eiPSC高效分化为角质形成细胞谱系的方法。假设eiPSC能够形成在形态和功能特征上与原代马角质形成细胞(PEK)相当的分化角质形成细胞(eiPSC-KC)。
体外实验研究。
使用非病毒系统建立的马iPSC用视黄酸和骨形态发生蛋白-4处理30天,以诱导定向分化为iPSC-KC。在分化的每周间隔以及对钙转换的反应中,测量eiPSC-KC的时空基因和蛋白质表达。将eiPSC-KC与PEK的增殖和迁移能力进行比较。
马iPSC在定向分化后,多能性基因表达丧失,全细胞角蛋白表达逐渐增加,表明向外胚层定向分化为角质形成细胞。在定向分化30天后,82.5%的eiPSC表达角蛋白14,这是表皮特异性基底干细胞的标志物,实现了高分化效率。此外,eiPSC-KC的增殖能力更强,而迁移能力(以体外伤口上皮化能力衡量)与PEK相当。
这项概念验证研究表明,eiPSC可以成功分化为马角质形成细胞(eiPSC-KC),其特征有望用于开发基于干细胞的皮肤构建体,具有再生缺失或受损皮肤的潜力。